First Albany Cuts Pfizer

Analyst Adam Greene says damaging Celebrex news will significantly impact the pharmaceutical giant's market growth

First Albany cuts Pfizer (PFE ) to neutral.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.